Fresenius FSNUY Stock
Fresenius Price Chart
Fresenius FSNUY Financial and Trading Overview
| Fresenius stock price | 14.72 USD |
| Previous Close | 14.69 USD |
| Open | 14.84 USD |
| Bid | 14.7 USD x 220000 |
| Ask | 14.72 USD x 210000 |
| Day's Range | 14.7 - 14.86 USD |
| 52 Week Range | 10.33 - 15.94 USD |
| Volume | 6.33K USD |
| Avg. Volume | 199.25K USD |
| Market Cap | 33.12B USD |
| Beta (5Y Monthly) | 0.771 |
| PE Ratio (TTM) | 17.926828 |
| EPS (TTM) | 0.82 USD |
| Forward Dividend & Yield | 0.3 (2.06%) |
| Ex-Dividend Date | May 26, 2026 |
| 1y Target Est | 16.33 USD |
FSNUY Valuation Measures
| Enterprise Value | 43.53B USD |
| Trailing P/E | 17.926828 |
| Forward P/E | 3.7701974 |
| PEG Ratio (5 yr expected) | 0.93 |
| Price/Sales (ttm) | 1.402785 |
| Price/Book (mrq) | 1.4374036 |
| Enterprise Value/Revenue | 1.844 |
| Enterprise Value/EBITDA | 14.053 |
Trading Information
Fresenius Stock Price History
| Beta (5Y Monthly) | 0.771 |
| 52-Week Change | 2.50% |
| S&P500 52-Week Change | 13.08% |
| 52 Week High | 15.94 USD |
| 52 Week Low | 10.33 USD |
| 50-Day Moving Average | 13.05 USD |
| 200-Day Moving Average | 12.85 USD |
FSNUY Share Statistics
| Avg. Volume (3 month) | 199.25K USD |
| Avg. Daily Volume (10-Days) | 108.25K USD |
| Shares Outstanding | 2.25B |
| Float | 1.64B |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.0069% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.05 |
| Trailing Annual Dividend Yield | 7.14% |
| 5 Year Average Dividend Yield | 279.00% |
| Payout Ratio | 0.37060001 |
| Last Split Factor | 3:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 6.56% |
| Operating Margin (ttm) | 9.92% |
| Gross Margin | 25.97% |
| EBITDA Margin | 13.12% |
Management Effectiveness
| Return on Assets (ttm) | 3.45% |
| Return on Equity (ttm) | 8.26% |
Income Statement
| Revenue (ttm) | 23.61B USD |
| Revenue Per Share (ttm) | 10.48 USD |
| Quarterly Revenue Growth (yoy) | 5.89% |
| Gross Profit (ttm) | 6.13B USD |
| EBITDA | 3.1B USD |
| Net Income Avi to Common (ttm) | 1.59B USD |
| Diluted EPS (ttm) | 0.82 |
| Quarterly Earnings Growth (yoy) | 7.79% |
Balance Sheet
| Total Cash (mrq) | 1.72B USD |
| Total Cash Per Share (mrq) | 0.76 USD |
| Total Debt (mrq) | 11.84B USD |
| Total Debt/Equity (mrq) | 57.04 USD |
| Current Ratio (mrq) | 1.52 |
| Book Value Per Share (mrq) | 10.226773 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.71B USD |
| Levered Free Cash Flow (ttm) | 352.75M USD |
Profile of Fresenius
| Country | United States |
| State | N/A |
| City | Bad Homburg vor der Höhe |
| Address | Else-Kröner-Straße 1 |
| ZIP | 61352 |
| Phone | 49 6172 6080 |
| Website | https://www.fresenius.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 179493 |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Q&A For Fresenius Stock
What is a current FSNUY stock price?
Fresenius FSNUY stock price today per share is 14.72 USD.
How to purchase Fresenius stock?
You can buy FSNUY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fresenius?
The stock symbol or ticker of Fresenius is FSNUY.
Which industry does the Fresenius company belong to?
The Fresenius industry is Medical Care Facilities.
How many shares does Fresenius have in circulation?
The max supply of Fresenius shares is 2.25B.
What is Fresenius Price to Earnings Ratio (PE Ratio)?
Fresenius PE Ratio is 17.95122000 now.
What was Fresenius earnings per share over the trailing 12 months (TTM)?
Fresenius EPS is 0.82 USD over the trailing 12 months.
Which sector does the Fresenius company belong to?
The Fresenius sector is Healthcare.
